Omnia owns a portfolio of sutures, irrigation tubing and customized dental surgical procedure kits, Little Falls, N.J.-based Cantel said. The newly acquired company’s products are intended for use across a number of dental surgical procedures.
Cantel Medical said that Omnia posted sales of $18.9 million for the 12 months ended July 31, 2018, and that it expects the acquisition to be accretive to its non-GAAP earnings per share in its 2019 fiscal year, and accretive to GAAP EPS beyond its 2020 fiscal year.
The purchase price includes $25.1 million in an upfront payment and $5.8 million in a milestone-based payout, according to the company’s initial announcement of the acquisition posted last November.
Cantel Medical said today in a press release that it closed the acquisition.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.